Asset Turnover (Quarterly)

Asset Turnover: The amount of sales or revenues generated per dollar of assets. The Asset Turnover ratio is an indicator of the efficiency with which a company is deploying its assets. Calculated as: Total Revenues / Total Assets

AMNEAL PHARMACEUTICALS, INC. (AMRX) had Asset Turnover of 0.21 for the most recently reported fiscal quarter, ending 2026-06-30.

Quarterly Annual

Figures for fiscal quarter ending 2026-06-30

Income Statement Financials
Revenue	$796.20M
Net Income	$57.66M
Cost of Goods Sold	$461.69M
Gross Profit	$334.51M
Operating Expenses	$666.43M
Operating Income	$129.77M
Non-Operating Income/Expense	$-58.78M
Pre-Tax Income	$70.99M
Normalized Pre-Tax Income	$70.99M
Income after Taxes	$69.61M
Income from Continuous Operations	$69.61M
Consolidated Net Income/Loss	$69.61M
Normalized Income after Taxes	$69.61M
EBIT	$129.77M
EBITDA	$181.63M
Weighted-Average Shares Outstanding (Basic)	319.20M
Weighted-Average Shares Outstanding (Diluted)	328.10M
Earnings per Share (EPS) (Basic)	$0.18
Earnings per Share (EPS) (Diluted)	$0.18
Balance Sheet Financials
Current Assets	$1.95B
Property, Plant, and Equipment	$456.88M
Long-Term Assets	$1.83B
Total Assets	$3.78B
Current Liabilities	$883.19M
Long-Term Debt	$2.56B
Long-Term Liabilities	$2.86B
Total Liabilities	$3.74B
Common Equity	$33.02M
Tangible Shareholders Equity	$-1.15B
Shareholders Equity	$33.02M
Common Shares Outstanding	319.33M
Cash Flow Statement Financials
Cash Flow from Operating Activities	$-47.99M
Cash Flow from Investing Activities	$-144.45M
Cash Flow from Financial Activities	$20.31M
Beginning Cash	$312.94M
End Cash	$139.62M
Increase/Decrease in Cash	$-173.32M
Stock-Based Compensation	$19.21M
Common Stock Dividends Paid	--
Preferred Stock Dividends Paid	--
Fundamental Metrics & Ratios
Current Ratio	2.20
Non-Performing Assets / Total Loans	--
Loan Loss Reserves / Non-Performing Loans	--
Debt to Capital Ratio	0.99
Debt to Equity Ratio	80.86
Gross Margin	42.01%
Operating Margin	16.30%
EBIT Margin	16.30%
EBITDA Margin	--
Pre-Tax Profit Margin	8.92%
Profit Margin	7.24%
Free Cash Flow	$-107.44M
Loss Ratio	--
Expense Ratio	--
Combined Ratio	--
Asset Turnover	0.21
Inventory Turnover	0.68
Receiveable Turnover	0.78
Days Sales in Receivables	115.39
Return on Equity	210.80%
Return on Tangible Equity	-6.06%
Return on Assets	1.84%
Return on Investments	2.68%
Book Value Per Share	$0.10
Free Cash Flow per Share	$-0.33
Operating Cash Flow per Share	$-0.15

Data from Zacks Investment Research, Inc.